Shrirang V Ranade

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 5

Top Topics

Age Related Macular Degeneration

Diabetic Retinopathy

Top Venues

Ophthalmology and therapy

This page only lists publications with an associated author ORCID identifier.

Publications

Nancy M Holekamp, Manejeh Yaqub, Shrirang V Ranade, Ronald A Cantrell, Sheena Singh, Gus Gazzard
Systematic Literature Reviews Comparing the Long-Term Safety Outcomes for the Port Delivery System with Ranibizumab (PDS) Versus Other Ocular Implants. Ophthalmology and therapy 13 (9) (2024)
Nancy M Holekamp, Manejeh Yaqub, Shrirang V Ranade, Ronald A Cantrell, Sheena Singh, Gus Gazzard
Systematic Literature Reviews Comparing the Long-Term Safety Outcomes for the Port Delivery System with Ranibizumab (PDS) Versus Other Ocular Implants. Ophthalmology and therapy 13 (9) (2024)
Nancy M Holekamp, Manejeh Yaqub, Shrirang V Ranade, Ronald A Cantrell, Sheena Singh, Gus Gazzard
Systematic Literature Reviews Comparing the Long-Term Safety Outcomes for the Port Delivery System with Ranibizumab (PDS) Versus Other Ocular Implants. Ophthalmology and therapy (2024)
Nancy M Holekamp, Manejeh Yaqub, Shrirang V Ranade, Ronald A Cantrell, Sheena Singh, Gus Gazzard
Systematic Literature Reviews Comparing the Long-Term Safety Outcomes for the Port Delivery System with Ranibizumab (PDS) Versus Other Ocular Implants. Ophthalmology and therapy 13 (9) (2024)
Shrirang V Ranade, Mark R Wieland, Tammy Tam, Jennifer C Rea, Judit Horvath, Aaron R Hieb, Weitao Jia, Lori Grace, Francesco Viola, Jay M Stewart
The Port Delivery System with ranibizumab: a new paradigm for long-acting retinal drug delivery. Drug delivery 29 (1) (2022)